Cancer Medicine by Alexandros G.Sfakianakis,Anapafseos 5 Agios Nikolaos,Crete 72100,Greece,tel :00302841026182 & 00306932607174
Δευτέρα 23 Νοεμβρίου 2020
A Study to Evaluate Camrelizumab Plus Apatinib as Adjuvant Therapy in Patients With HCC at High Risk of Recurrence After Surgical Resection or Ablation
Cancer shared this article with you from Inoreader
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου